Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hatch Biofund is a life sciences venture capital firm based in the Philadelphia region, focused on early-stage capital for promising biotech companies. Founded to support the development of therapeutics and vaccines, the firm combines financial backing with industry expertise and physical platforms. It invests across various stages, including pre-seed to Series C, with a keen interest in capital efficiency and societal value.
Hatch Biofund exclusively invests in private companies developing therapeutics and vaccines for human use. The firm targets all development stages and diverse treatment modalities, such as small molecules, cell therapy, and gene therapy. A clear understanding of disease biology and efficient development pathways are critical to their investment thesis.
Notable portfolio companies include Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company; Latus Bio, focused on gene therapy for CNS diseases; Hula Therapeutics, an immunotherapy spinout from the Children's Hospital of Philadelphia; MasterSwitch Bio, developing modified mRNA therapies; and Ladder Bio, creating a novel chemical platform for selective binding molecules.
Submit your pitch through their website's contact form for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.